Multiple Myeloma

PDUFA test
Tue, 04/10/18 - 12:16 am
Celgene, bluebird revise deal to co-develop CAR-T therapy
Biopharma Dive
Thu, 03/29/18 - 11:33 am
Celgene
Bluebird Bio
drug development
CAR-T
bb2121
Multiple Myeloma
Looking to grow blockbuster Pomalyst franchise, Celgene declares a win for multiple myeloma triplet in pivotal PhIII
Endpoints
Tue, 02/6/18 - 09:50 am
Celgene
Pomalyst
Multiple Myeloma
clinical trials
Amgen kicks off 2018 with double the good news for slow-growing Kyprolis
Fierce Pharma
Thu, 01/18/18 - 10:30 pm
Amgen
Kyprolis
Multiple Myeloma
FDA expands use of Amgen's blockbuster drug
Yahoo/Reuters
Fri, 01/5/18 - 05:42 pm
FDA
Amgen
Xgeva
Multiple Myeloma
Amgen's Kyprolis improves overall survival in blood cancer patients
Reuters
Tue, 12/12/17 - 10:47 pm
Amgen
Kyprolis
Multiple Myeloma
ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half
Fierce Pharma
Tue, 12/12/17 - 10:06 am
ASH17
JNJ
Darzalex
Multiple Myeloma
Janssen
bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results
Motley Fool
Mon, 12/11/17 - 10:02 am
Bluebird Bio
bb2121
CAR-T
Celgene
Multiple Myeloma
ASH17
Juno inks deals with Eli Lilly as it looks to leapfrog leaders on BCMA
Endpoints
Thu, 12/7/17 - 08:56 am
Juno Therapeutics
Eli Lilly
LY3039478
Multiple Myeloma
J&J multiple myeloma drug succeeds in first-line combination study
Yahoo/Reuters
Tue, 11/21/17 - 09:50 am
JNJ
Multiple Myeloma
clinical trials
Darzalex
FDA orders Bristol-Myers’ Opdivo to the sidelines on 3 studies as regulators explore dangers of checkpoint combos
Endpoints
Wed, 09/6/17 - 08:57 pm
FDA
Bristol-Myers Squibb
Opdivo
clinical trials
Multiple Myeloma
FDA Alerts on Risks From Merck’s Keytruda in Multiple Myeloma Following Halted Trials
RAPS.org
Thu, 08/31/17 - 10:17 pm
FDA
Merck
Keytruda
Multiple Myeloma
Genmab gains on promising early success for daratumumab PhIII in multiple myeloma, but questions linger
Endpoints
Fri, 08/25/17 - 09:49 am
Genmab
daratumumab
Darzalex
Multiple Myeloma
clinical trials
What Kyprolis Could Do for Amgen’s Revenue Growth
Market Realist
Tue, 08/15/17 - 09:38 am
Kyprolis
Amgen
Multiple Myeloma
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Fierce Pharma
Fri, 07/14/17 - 07:54 am
Amgen
Kyprolis
Revlimid
Celgene
Takeda
Velcade
Multiple Myeloma
What the FDA's Hold on Three Merck Studies Means for Other Drug Makers
TheStreet.com
Sun, 07/9/17 - 07:44 pm
Merck
Keytruda
FDA
clinical trials
Multiple Myeloma
Bristol-Myers Squibb
AstraZeneca
Celgene
Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
Endpoints
Wed, 07/5/17 - 07:06 pm
FDA
Merck
Keytruda
clinical trials
Multiple Myeloma
Johnson & Johnson nabs another combo approval for myeloma star Darzalex
Fierce Pharma
Mon, 06/19/17 - 03:13 pm
JNJ
Multiple Myeloma
Darzalex
Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate of deaths
Endpoints
Mon, 06/12/17 - 09:37 pm
Merck
Keytruda
clinical trials
Multiple Myeloma
Takeda starts work on €40M plant to produce multiple myeloma drug Ninlaro
Fierce Pharma
Wed, 06/7/17 - 12:10 pm
Takeda
drug manufacturing
Multiple Myeloma
Ninlaro

Pages